News
Why Shares of Palo Alto Networks Are Soaring Today
Shares of cybersecurity company Palo Alto Networks (NYSE: PANW) jumped on Friday following a better-than-expected fiscal fourth-quarter report. Palo Alto beat analyst estimates for both revenue....
How Square, Inc. Makes Most of Its Money
Tech investors scanning the horizon for potential investments have likely come across the point-of-sale and payment processing company Square (NYSE: SQ). The company's share price is up a....
DOW DAX an der Trendlinie
Jetzt wird es wieder spannend, schafft der DAX diesmal den Ausbruch, oder scheitert er erneut kläglich. Erneut muss der DOW ihm dabei helfen und selbst die 22000 überwinden, um den Weg nach oben frei
Warren Buffett Is Now the Biggest Shareholder of Two Massive Banks
The most important person in the bank industry isn't a banker -- it's Warren Buffett, the chairman and CEO of Berkshire Hathaway (NYSE: BRK-A) (NYSE: BRK-B).He cemented that role this week, by....
Better Buy: Intel Corporation vs. Texas Instruments
There are a host of similarities between Texas Instruments (NASDAQ: TXN) and Intel (NASDAQ: INTC) despite the fact that each plays in a different tech sandbox. Both pay outstanding dividends, and....
You'll Be Surprised at the Size of Cisco's War Chest
When investors think of Cisco (NASDAQ: CSCO), they probably think of a dull, mature tech company that barely generates any growth with its aging businesses of routers and switches. They'd be....
Tesla, Inc.: Demand Is "Strong" for Solar Tiles
Tesla's (NASDAQ: TSLA) cell production for its solar roof tiles, which were announced in May, is finally underway at the company's Buffalo, New York, factory, according to a new report from the....
3 Dates to Circle in September
Summer's heating up and heading out, but that doesn't mean that investors can tap the snooze bar and belt out that Green Day tune about waking up after September ends. Earnings season may be....
Is eBay Stock a Buy?
It's hard to believe, but eBay's (NASDAQ: EBAY) stock has actually outperformed the S&P 500 Index over the last 3, 5, and 10 year periods. Keep in mind, a lot of this performance was driven by....
The Simple Reason I Won't Buy Intrexon
"Complexity" is one of the most adequate words that can be used to describe synthetic biology conglomerate Intrexon (NYSE: XON). The company's management team, Wall Street analysts, and even....
lululemon athletica Accelerates Growth, Raises Guidance
Three months ago, shares of lululemon athletica (NASDAQ: LULU) jumped higher after the company not only beat expectations with its fiscal first-quarter results but also announced it would....
Should Expedia Investors Be Worried About Their CEO's Departure?
It's never easy for a company to lose its leader, particularly when that person was on the throne for many years and enjoyed a reputation for level-headedness and calm. That's the situation at....
3 Stocks That Could Soar More Than Amazon
There are few stocks that have been more exciting over the past few years than Amazon.com (NASDAQ: AMZN). Shares of the e-commerce and cloud computing giant have soared nearly 190% over the past....
In Your 60s? 3 Stocks You Should Consider Buying
In your 60s, wealth accumulation becomes less important than safety. As you approach retirement, you're probably focusing on the next financial stage: living off of your nest egg. It means you....
What the Biggest Investors Are Doing About Opko Health Stock's Dismal Performance
So far in 2017, Opko Health (NASDAQ: OPK) has lost roughly one-third of its market cap. The stock finished 2016 down 7% due to an end-of-year plunge.Things aren't going well for multiple reasons.....
2 Beaten Up Dividend Aristocrats: Are They Bargains?
Income-seeking investors love buying dividend aristocrats -- stocks that have increased their dividends for more than years -- so when their stock prices fall it's a good idea to look at buying....
Better Buy: Apache Corp. vs. Devon Energy
If you want to compare apples to apples in the oil industry, you can't do much better than looking at Devon Energy (NYSE: DVN) and Apache Corporation (NYSE: APA). The companies have nearly....
GlaxoSmithKline Is Wasting Money Paying a Dividend
As a general rule, I love companies that pay big dividends -- and British pharmaceutical giant GlaxoSmithKline (NYSE: GSK) pays some of the best dividends on the planet. That said, there's one....
Can Illinois Tool Works Weather an Economic Downturn?
Industrial products and equipment powerhouse Illinois Tool Works (NYSE: ITW) has reliably created shareholder value over the long term. The company has delivered record EPS year after year, has....
3 Dividend Stocks That Thrive in Bear Markets
One of the benefits of dividend investing is the comfort that comes from the regular income stream. But market downturns can many times throw that sense of security out the window. What income....
4 Reasons General Motors Thinks You Should Buy GM Stock
General Motors' (NYSE: GM) top executives want you to know something: They think GM stock is a strong buy. Lately, they've stepped up their efforts to make the case to Wall Street -- and to....
You Wouldn't Believe the Size of Amazon.com, Inc.'s Cash Flows
Critics of Amazon.com (NASDAQ: AMZN) often point out that the e-tailer's earnings are slim and unpredictable. Hence, Amazon's price-to-earnings (P/E) ratios tend to sit in the nosebleed section....
Why I (Still) Love NVIDIA Corporation
It's easy to see why some NVIDIA (NASDAQ: NVDA) analysts are becoming cautious. With a price up 55% in 2017, and a whopping 166% the past year, NVIDIA stock is trading well above industry averages....
You Wouldn't Believe the Size of HCP Inc.'s Market Opportunity
It's been almost a year since healthcare real estate investment trust HCP, Inc. (NYSE: HCP) spun off its skilled nursing assets and decided to focus on its core property types -- senior housing,....
Novartis $475,000 Price Tag Sets the Stage for a Price War With Gilead Sciences
On Monday, Gilead Sciences' (NASDAQ: GILD) wowed investors with an $11.9 billion deal to buy clinical-stage CAR-T drugmaker Kite Pharma (NASDAQ: KITE), and on Wednesday, the FDA approved Novartis'....